 | • レポートコード：MRC2-11QY06836 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は緑内障医薬品のグローバル市場について調査・分析したレポートです。種類別（プロスタグランジン類似体（PGA）、非PGA）市場規模、用途別（病院薬局、私立クリニック、ドラッグストア、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別緑内障医薬品の競争状況、市場シェア ・世界の緑内障医薬品市場：種類別市場規模 2015年-2020年（プロスタグランジン類似体（PGA）、非PGA） ・世界の緑内障医薬品市場：種類別市場規模予測 2021年-2026年（プロスタグランジン類似体（PGA）、非PGA） ・世界の緑内障医薬品市場：用途別市場規模 2015年-2020年（病院薬局、私立クリニック、ドラッグストア、小売薬局、Eコマース） ・世界の緑内障医薬品市場：用途別市場規模予測 2021年-2026年（病院薬局、私立クリニック、ドラッグストア、小売薬局、Eコマース） ・北米の緑内障医薬品市場分析：米国、カナダ ・ヨーロッパの緑内障医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの緑内障医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の緑内障医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの緑内障医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acadia Pharmaceuticals Inc.、Allergan Inc.、Inotek Pharmaceuticals Corporation、Merck & Co. Inc.、Santen Pharmaceutical Co.Ltd.、Novartis International AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented.
Market Analysis and Insights: Global Glaucoma Pharmaceuticals Market
The global Glaucoma Pharmaceuticals market size is projected to reach US$ 3315.4 million by 2026, from US$ 3255.5 million in 2020, at a CAGR of 1.7%% during 2021-2026.
Global Glaucoma Pharmaceuticals Scope and Market Size
Glaucoma Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glaucoma Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glaucoma Pharmaceuticals market is segmented into
Prostaglandins Analogues (PGAs)
Non PGAs
Segment by Application, the Glaucoma Pharmaceuticals market is segmented into
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Regional and Country-level Analysis
The Glaucoma Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glaucoma Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glaucoma Pharmaceuticals Market Share Analysis
Glaucoma Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glaucoma Pharmaceuticals business, the date to enter into the Glaucoma Pharmaceuticals market, Glaucoma Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Acadia Pharmaceuticals Inc.
Allergan Inc.
Inotek Pharmaceuticals Corporation
Merck & Co. Inc.
Santen Pharmaceutical Co.Ltd.
Novartis International AG
…
1 Study Coverage
1.1 Glaucoma Pharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Glaucoma Pharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glaucoma Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Prostaglandins Analogues (PGAs)
1.4.3 Non PGAs
1.5 Market by Application
1.5.1 Global Glaucoma Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Drug Stores
1.5.5 Retail Pharmacies
1.5.6 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glaucoma Pharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Glaucoma Pharmaceuticals Revenue 2015-2026
2.1.2 Global Glaucoma Pharmaceuticals Sales 2015-2026
2.2 Global Glaucoma Pharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glaucoma Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glaucoma Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glaucoma Pharmaceuticals Competitor Landscape by Players
3.1 Glaucoma Pharmaceuticals Sales by Manufacturers
3.1.1 Glaucoma Pharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Glaucoma Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Glaucoma Pharmaceuticals Revenue by Manufacturers
3.2.1 Glaucoma Pharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Glaucoma Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glaucoma Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glaucoma Pharmaceuticals Revenue in 2019
3.2.5 Global Glaucoma Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glaucoma Pharmaceuticals Price by Manufacturers
3.4 Glaucoma Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Glaucoma Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glaucoma Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Glaucoma Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glaucoma Pharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Glaucoma Pharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Glaucoma Pharmaceuticals Revenue by Type (2015-2020)
4.1.3 Glaucoma Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glaucoma Pharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Glaucoma Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Glaucoma Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Glaucoma Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glaucoma Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glaucoma Pharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Glaucoma Pharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Glaucoma Pharmaceuticals Revenue by Application (2015-2020)
5.1.3 Glaucoma Pharmaceuticals Price by Application (2015-2020)
5.2 Glaucoma Pharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Glaucoma Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Glaucoma Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Glaucoma Pharmaceuticals Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glaucoma Pharmaceuticals by Country
6.1.1 North America Glaucoma Pharmaceuticals Sales by Country
6.1.2 North America Glaucoma Pharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glaucoma Pharmaceuticals Market Facts & Figures by Type
6.3 North America Glaucoma Pharmaceuticals Market Facts & Figures by Application
7 Europe
7.1 Europe Glaucoma Pharmaceuticals by Country
7.1.1 Europe Glaucoma Pharmaceuticals Sales by Country
7.1.2 Europe Glaucoma Pharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glaucoma Pharmaceuticals Market Facts & Figures by Type
7.3 Europe Glaucoma Pharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glaucoma Pharmaceuticals by Region
8.1.1 Asia Pacific Glaucoma Pharmaceuticals Sales by Region
8.1.2 Asia Pacific Glaucoma Pharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glaucoma Pharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Glaucoma Pharmaceuticals Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glaucoma Pharmaceuticals by Country
9.1.1 Latin America Glaucoma Pharmaceuticals Sales by Country
9.1.2 Latin America Glaucoma Pharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glaucoma Pharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Glaucoma Pharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glaucoma Pharmaceuticals by Country
10.1.1 Middle East and Africa Glaucoma Pharmaceuticals Sales by Country
10.1.2 Middle East and Africa Glaucoma Pharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glaucoma Pharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Glaucoma Pharmaceuticals Market Facts & Figures by Application
11 Company Profiles
11.1 Acadia Pharmaceuticals Inc.
11.1.1 Acadia Pharmaceuticals Inc. Corporation Information
11.1.2 Acadia Pharmaceuticals Inc. Description and Business Overview
11.1.3 Acadia Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Products Offered
11.1.5 Acadia Pharmaceuticals Inc. Related Developments
11.2 Allergan Inc.
11.2.1 Allergan Inc. Corporation Information
11.2.2 Allergan Inc. Description and Business Overview
11.2.3 Allergan Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Inc. Glaucoma Pharmaceuticals Products Offered
11.2.5 Allergan Inc. Related Developments
11.3 Inotek Pharmaceuticals Corporation
11.3.1 Inotek Pharmaceuticals Corporation Corporation Information
11.3.2 Inotek Pharmaceuticals Corporation Description and Business Overview
11.3.3 Inotek Pharmaceuticals Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Products Offered
11.3.5 Inotek Pharmaceuticals Corporation Related Developments
11.4 Merck & Co. Inc.
11.4.1 Merck & Co. Inc. Corporation Information
11.4.2 Merck & Co. Inc. Description and Business Overview
11.4.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co. Inc. Glaucoma Pharmaceuticals Products Offered
11.4.5 Merck & Co. Inc. Related Developments
11.5 Santen Pharmaceutical Co.Ltd.
11.5.1 Santen Pharmaceutical Co.Ltd. Corporation Information
11.5.2 Santen Pharmaceutical Co.Ltd. Description and Business Overview
11.5.3 Santen Pharmaceutical Co.Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Products Offered
11.5.5 Santen Pharmaceutical Co.Ltd. Related Developments
11.6 Novartis International AG
11.6.1 Novartis International AG Corporation Information
11.6.2 Novartis International AG Description and Business Overview
11.6.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis International AG Glaucoma Pharmaceuticals Products Offered
11.6.5 Novartis International AG Related Developments
11.1 Acadia Pharmaceuticals Inc.
11.1.1 Acadia Pharmaceuticals Inc. Corporation Information
11.1.2 Acadia Pharmaceuticals Inc. Description and Business Overview
11.1.3 Acadia Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Products Offered
11.1.5 Acadia Pharmaceuticals Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glaucoma Pharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Glaucoma Pharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Glaucoma Pharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Glaucoma Pharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Glaucoma Pharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Glaucoma Pharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Glaucoma Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Glaucoma Pharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Glaucoma Pharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Glaucoma Pharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Glaucoma Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glaucoma Pharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glaucoma Pharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glaucoma Pharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glaucoma Pharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Glaucoma Pharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Glaucoma Pharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Glaucoma Pharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Glaucoma Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glaucoma Pharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glaucoma Pharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glaucoma Pharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glaucoma Pharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glaucoma Pharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glaucoma Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Glaucoma Pharmaceuticals Market Segments
Table 2. Ranking of Global Top Glaucoma Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glaucoma Pharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prostaglandins Analogues (PGAs)
Table 5. Major Manufacturers of Non PGAs
Table 6. Global Glaucoma Pharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Glaucoma Pharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Glaucoma Pharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 9. Global Glaucoma Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 10. Global Glaucoma Pharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Glaucoma Pharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Glaucoma Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 13. Global Glaucoma Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Glaucoma Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Pharmaceuticals as of 2019)
Table 15. Glaucoma Pharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Glaucoma Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Glaucoma Pharmaceuticals Price (2015-2020) (USD/Unit)
Table 18. Glaucoma Pharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Glaucoma Pharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into Glaucoma Pharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Glaucoma Pharmaceuticals Sales by Type (2015-2020) (K Units)
Table 23. Global Glaucoma Pharmaceuticals Sales Share by Type (2015-2020)
Table 24. Global Glaucoma Pharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Glaucoma Pharmaceuticals Revenue Share by Type (2015-2020)
Table 26. Glaucoma Pharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Glaucoma Pharmaceuticals Sales by Application (2015-2020) (K Units)
Table 28. Global Glaucoma Pharmaceuticals Sales Share by Application (2015-2020)
Table 29. North America Glaucoma Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 30. North America Glaucoma Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 31. North America Glaucoma Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Glaucoma Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 33. North America Glaucoma Pharmaceuticals Sales by Type (2015-2020) (K Units)
Table 34. North America Glaucoma Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 35. North America Glaucoma Pharmaceuticals Sales by Application (2015-2020) (K Units)
Table 36. North America Glaucoma Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 37. Europe Glaucoma Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 38. Europe Glaucoma Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 39. Europe Glaucoma Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Glaucoma Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 41. Europe Glaucoma Pharmaceuticals Sales by Type (2015-2020) (K Units)
Table 42. Europe Glaucoma Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. Europe Glaucoma Pharmaceuticals Sales by Application (2015-2020) (K Units)
Table 44. Europe Glaucoma Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Glaucoma Pharmaceuticals Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Glaucoma Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Glaucoma Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Glaucoma Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Glaucoma Pharmaceuticals Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Glaucoma Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Glaucoma Pharmaceuticals Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Glaucoma Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 53. Latin America Glaucoma Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 54. Latin America Glaucoma Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Glaucoma Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Glaucoma Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 57. Latin America Glaucoma Pharmaceuticals Sales by Type (2015-2020) (K Units)
Table 58. Latin America Glaucoma Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 59. Latin America Glaucoma Pharmaceuticals Sales by Application (2015-2020) (K Units)
Table 60. Latin America Glaucoma Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Glaucoma Pharmaceuticals Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Glaucoma Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Glaucoma Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Glaucoma Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Glaucoma Pharmaceuticals Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Glaucoma Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Glaucoma Pharmaceuticals Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Glaucoma Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. Acadia Pharmaceuticals Inc. Corporation Information
Table 70. Acadia Pharmaceuticals Inc. Description and Major Businesses
Table 71. Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Acadia Pharmaceuticals Inc. Product
Table 73. Acadia Pharmaceuticals Inc. Recent Development
Table 74. Allergan Inc. Corporation Information
Table 75. Allergan Inc. Description and Major Businesses
Table 76. Allergan Inc. Glaucoma Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Allergan Inc. Product
Table 78. Allergan Inc. Recent Development
Table 79. Inotek Pharmaceuticals Corporation Corporation Information
Table 80. Inotek Pharmaceuticals Corporation Description and Major Businesses
Table 81. Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Inotek Pharmaceuticals Corporation Product
Table 83. Inotek Pharmaceuticals Corporation Recent Development
Table 84. Merck & Co. Inc. Corporation Information
Table 85. Merck & Co. Inc. Description and Major Businesses
Table 86. Merck & Co. Inc. Glaucoma Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Merck & Co. Inc. Product
Table 88. Merck & Co. Inc. Recent Development
Table 89. Santen Pharmaceutical Co.Ltd. Corporation Information
Table 90. Santen Pharmaceutical Co.Ltd. Description and Major Businesses
Table 91. Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Santen Pharmaceutical Co.Ltd. Product
Table 93. Santen Pharmaceutical Co.Ltd. Recent Development
Table 94. Novartis International AG Corporation Information
Table 95. Novartis International AG Description and Major Businesses
Table 96. Novartis International AG Glaucoma Pharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Novartis International AG Product
Table 98. Novartis International AG Recent Development
Table 99. Global Glaucoma Pharmaceuticals Sales Forecast by Regions (2021-2026) (K Units)
Table 100. Global Glaucoma Pharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Glaucoma Pharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Glaucoma Pharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Glaucoma Pharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 104. North America: Glaucoma Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Glaucoma Pharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 106. Europe: Glaucoma Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Glaucoma Pharmaceuticals Sales Forecast by Region (2021-2026) (K Units)
Table 108. Asia Pacific: Glaucoma Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Glaucoma Pharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 110. Latin America: Glaucoma Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Glaucoma Pharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 112. Middle East and Africa: Glaucoma Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Glaucoma Pharmaceuticals Players
Table 117. Glaucoma Pharmaceuticals Customers List
Table 118. Glaucoma Pharmaceuticals Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Glaucoma Pharmaceuticals Product Picture
Figure 2. Global Glaucoma Pharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Prostaglandins Analogues (PGAs) Product Picture
Figure 4. Non PGAs Product Picture
Figure 5. Global Glaucoma Pharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Private Clinics
Figure 8. Drug Stores
Figure 9. Retail Pharmacies
Figure 10. E-Commerce
Figure 11. Glaucoma Pharmaceuticals Report Years Considered
Figure 12. Global Glaucoma Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global Glaucoma Pharmaceuticals Sales 2015-2026 (K Units)
Figure 14. Global Glaucoma Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Glaucoma Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global Glaucoma Pharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global Glaucoma Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global Glaucoma Pharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global Glaucoma Pharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Glaucoma Pharmaceuticals Revenue in 2019
Figure 21. Glaucoma Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Glaucoma Pharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global Glaucoma Pharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global Glaucoma Pharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global Glaucoma Pharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global Glaucoma Pharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global Glaucoma Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global Glaucoma Pharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global Glaucoma Pharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global Glaucoma Pharmaceuticals Revenue Market Share by Application in 2019
Figure 31. North America Glaucoma Pharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Glaucoma Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Glaucoma Pharmaceuticals Sales Market Share by Country in 2019
Figure 34. North America Glaucoma Pharmaceuticals Revenue Market Share by Country in 2019
Figure 35. U.S. Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Glaucoma Pharmaceuticals Market Share by Type in 2019
Figure 40. North America Glaucoma Pharmaceuticals Market Share by Application in 2019
Figure 41. Europe Glaucoma Pharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Glaucoma Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Glaucoma Pharmaceuticals Sales Market Share by Country in 2019
Figure 44. Europe Glaucoma Pharmaceuticals Revenue Market Share by Country in 2019
Figure 45. Germany Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Glaucoma Pharmaceuticals Market Share by Type in 2019
Figure 56. Europe Glaucoma Pharmaceuticals Market Share by Application in 2019
Figure 57. Asia Pacific Glaucoma Pharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Glaucoma Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Glaucoma Pharmaceuticals Sales Market Share by Region in 2019
Figure 60. Asia Pacific Glaucoma Pharmaceuticals Revenue Market Share by Region in 2019
Figure 61. China Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Glaucoma Pharmaceuticals Market Share by Type in 2019
Figure 84. Asia Pacific Glaucoma Pharmaceuticals Market Share by Application in 2019
Figure 85. Latin America Glaucoma Pharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Glaucoma Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Glaucoma Pharmaceuticals Sales Market Share by Country in 2019
Figure 88. Latin America Glaucoma Pharmaceuticals Revenue Market Share by Country in 2019
Figure 89. Mexico Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Glaucoma Pharmaceuticals Market Share by Type in 2019
Figure 96. Latin America Glaucoma Pharmaceuticals Market Share by Application in 2019
Figure 97. Middle East and Africa Glaucoma Pharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Glaucoma Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Glaucoma Pharmaceuticals Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Glaucoma Pharmaceuticals Revenue Market Share by Country in 2019
Figure 101. Turkey Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Glaucoma Pharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Glaucoma Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Glaucoma Pharmaceuticals Market Share by Type in 2019
Figure 108. Middle East and Africa Glaucoma Pharmaceuticals Market Share by Application in 2019
Figure 109. North America Glaucoma Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Glaucoma Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Glaucoma Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Glaucoma Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Glaucoma Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Glaucoma Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Glaucoma Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Glaucoma Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Glaucoma Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Glaucoma Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
緑内障治療薬の世界市場（～2026年） Market Analysis and Insights: Global Glaucoma Treatment Drugs Market The global Glaucoma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glaucoma Treatment Drugs Scope and Market Size Glaucoma Treatment…- 緑内障ドレナージ装置の世界市場（～2026年） Market Analysis and Insights: Global Glaucoma Drainage Devices Market The global Glaucoma Drainage Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glaucoma Drainage Devices Scope and Market Size Glaucoma Draina…
- 緑内障の世界市場（～2026年） Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may resul…
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- 向精神薬の世界市場（～2026年） Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior. The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of…